cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Passage Bio Inc
2 own
7 watching
Current Price
$1.55
$-0.01
(-0.64%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
84.55M
52-Week High
52-Week High
5
52-Week Low
52-Week Low
1.04
Average Volume
Average Volume
0.1M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization84.55M
icon52-Week High5
icon52-Week Low1.04
iconAverage Volume0.1M
iconDividend Yield--
iconP/E Ratio--
What does the Passage Bio Inc do?
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD-GRN; and PBKR03, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and PBCM06 for the treatment of Charcot-Marie-Tooth Type 2A. Passage Bio, Inc. has a strategic research collaboration with the Trustees of the University of Pennsylvania s Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Read More
How much money does Passage Bio Inc make?
News & Events about Passage Bio Inc.
Globe Newswire
3 months ago
PHILADELPHIA, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced the appointment of William Chou, M.D. as chief executive officer (...
Globe Newswire
6 months ago
PHILADELPHIA, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that Simona King, chief financial officer of Passage Bio, will ...
Ticker Report
8 months ago
Zacks Investment Research cut shares of Passage Bio (NASDAQ:PASG Get Rating) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning, Zacks.com reports. According to Zacks, Passage Bio Inc. is a genetic medicines company. It is focused on ...
Globe Newswire
9 months ago
PHILADELPHIA, May 03, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that additional clinical and biomarker data from Cohort 1 in the ...
Frequently Asked Questions
Frequently Asked Questions
What is Passage Bio Inc share price today?
plus_minus_icon
Can Indians buy Passage Bio Inc shares?
plus_minus_icon
How can I buy Passage Bio Inc shares from India?
plus_minus_icon
Can Fractional shares of Passage Bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Passage Bio Inc stocks?
plus_minus_icon
What is today’s traded volume of Passage Bio Inc?
plus_minus_icon
What is today’s market capitalisation of Passage Bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Passage Bio Inc?
plus_minus_icon
What percentage is Passage Bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Passage Bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.55
$-0.01
(-0.64%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00